NORMAL SITUATION

ANGHIL-PHARMA

Financial year 2025 · closed on 31/12/2025
Net result
-688,8 €
-114.4% YoY
Gross margin
15,4 k €
-15.6% YoY
Equity
7,6 k €
-8.3% YoY

Company — Normal situation.

Strike-off: 17 juillet 2026

What does ANGHIL-PHARMA do?

ANGHIL-PHARMA is a Private company with limited liability incorporated in 2002. Its main activity is: Dispensing chemist in specialised stores.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0476.700.461
Incorporation
18/01/2002
Legal form
Private company with limited liability
Contributed capital
18 600,00 €
Latest accounts
31/12/2025
Joint committees (1)
  • 313
Signals
Positive cashflowPositive EBITDA
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 20 financial years

20252024202320222021202020192018201720162015201420132012201120102009200820072006
Income statement
Gross margin15,4 k €18,3 k €13,9 k €16,6 k €6,2 k €12,8 k €9,1 k €1,9 k €187,4 k €51,8 k €72,3 k €62,5 k €53,9 k €38,4 k €54,9 k €49,3 k €60,2 k €79,5 k €22,1 k €16,7 k €
EBITDA14,7 k €17,2 k €12,7 k €15,8 k €5,9 k €12,5 k €8,7 k €1,5 k €187,1 k €51,4 k €64,3 k €51 k €52,3 k €38,1 k €54,1 k €48,8 k €59,2 k €78,9 k €21 k €14,1 k €
Operating result1,2 k €8,8 k €4,8 k €8,6 k €5,3 k €11,9 k €8,5 k €1,3 k €187,1 k €50,9 k €63,8 k €50,4 k €49,7 k €35,5 k €27,6 k €22,7 k €33,1 k €56 k €-5,3 k €-37,5 k €
Net result-688,8 €4,8 k €3,5 k €7,4 k €5,2 k €11,8 k €8 k €-3,1 k €167,2 k €21,3 k €30,2 k €15,6 k €11,6 k €-3,3 k €-14,5 k €-22,2 k €-19,1 k €18,3 k €-28,8 k €-53,9 k €
Balance sheet
Equity7,6 k €8,3 k €3,5 k €-19,3 €-7,5 k €-12,7 k €-24,5 k €-32,4 k €-29,4 k €-196,6 k €-217,8 k €-248 k €-263,6 k €-287,6 k €-284,3 k €-269,7 k €-247,5 k €-228,4 k €-246,7 k €-217,9 k €
Total assets75,7 k €90,3 k €32,1 k €39,9 k €6,2 k €7,3 k €5 k €30 k €50,6 k €80,6 k €104 k €93,2 k €98,8 k €121,5 k €96,1 k €126,8 k €189 k €188,4 k €189,8 k €279,4 k €
Cash5 k €3,1 k €8,2 k €8,8 k €5 k €3,3 k €2,7 k €28,1 k €49,6 k €23 k €12 k €17,2 k €22,5 k €25,9 k €9,3 k €9,6 k €43,3 k €31,6 k €11,5 k €44,9 k €
Debts68,1 k €82 k €28,6 k €39,9 k €13,7 k €20 k €29,5 k €62,5 k €80 k €277,2 k €321,3 k €340,5 k €345,5 k €398,2 k €379,3 k €393 k €431,4 k €414,7 k €424,4 k €492,4 k €
Other
Workforce0,1 ETP0,6 ETP0,2 ETP
Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 6 ended

Active mandates

Hilde Van Bellinghen

Director · since 27 août 2008

Active

Ended mandates

Hilde Van Bellinghen

Manager · since 27 août 2008

Ended
Angélique Barbier

Manager · since 19 décembre 2007

Ended
FEBELFARMA

Manager · since 19 décembre 2007 · 0479.127.936

Represented by Coene Frank

Ended
Hilde Van Bellinghen

Manager · since 19 décembre 2007

Ended
Annual accounts

Full financial information

202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date01/08/202625/08/202531/07/202429/08/202308/07/202227/07/2021
General meeting01/06/202602/06/202504/06/202405/06/202306/06/202207/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

20 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202501/06/202601/08/2026DutchPDF
Micro model31/12/202402/06/202525/08/2025DutchPDF
Micro model31/12/202304/06/202431/07/2024DutchPDF
Micro model31/12/202205/06/202329/08/2023DutchPDF
Micro model31/12/202106/06/202208/07/2022DutchPDF
Micro model31/12/202007/06/202127/07/2021DutchPDF
Micro model31/12/201901/06/202023/06/2020DutchPDF
Micro model31/12/201803/06/201911/07/2019DutchPDF
Micro model31/12/201704/06/201812/06/2018DutchPDF
Micro model31/12/201605/06/201703/07/2017DutchPDF
Abridged model31/12/201530/06/201631/08/2016DutchPDF
Abridged model31/12/201430/06/201525/08/2015DutchPDF
Abridged model31/12/201330/06/201430/07/2014DutchPDF
Abridged model31/12/201229/06/201302/08/2013DutchPDF
Abridged model31/12/201104/06/201211/06/2012DutchPDF
Abridged model31/12/201029/06/201126/08/2011DutchPDF
Abridged model31/12/200907/06/201024/06/2010DutchPDF
Abridged model31/12/200801/06/200901/07/2009DutchPDF
Abridged model31/12/200711/06/200810/07/2008DutchPDF
Abridged model31/12/200613/06/200730/07/2007DutchPDF
Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 6 ended

Active mandates

Hilde Van Bellinghen

Director · since 27 août 2008

Active

Ended mandates

Hilde Van Bellinghen

Manager · since 27 août 2008

Ended
Angélique Barbier

Manager · since 19 décembre 2007

Ended
FEBELFARMA

Manager · since 19 décembre 2007 · 0479.127.936

Represented by Coene Frank

Ended
Hilde Van Bellinghen

Manager · since 19 décembre 2007

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Dissolution24/07/2026
    RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ...
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-688,8 €
  2. 2024
    Annual accounts 20244,8 k €
  3. 2023
    Annual accounts 20233,5 k €
  4. 2022
    Annual accounts 20227,4 k €
  5. 2021
    Annual accounts 20215,2 k €
  6. 2020
    Annual accounts 202011,8 k €
  7. 2019
    Annual accounts 20198 k €
  8. 2018
    Annual accounts 2018-3,1 k €
  9. 2017
    Annual accounts 2017167,2 k €
  10. 2016
    Annual accounts 201621,3 k €
  11. 2015
    Annual accounts 201530,2 k €
  12. 2014
    Annual accounts 201415,6 k €
  13. 2013
    Annual accounts 201311,6 k €
  14. 2012
    Annual accounts 2012-3,3 k €
  15. 2011
    Annual accounts 2011-14,5 k €
  16. 2010
    Annual accounts 2010-22,2 k €
  17. 2009
    Annual accounts 2009-19,1 k €
  18. 2008
    Annual accounts 200818,3 k €
  19. 2007
    Annual accounts 2007-28,8 k €
  20. 2006
    Annual accounts 2006-53,9 k €
  21. 18/01/2002
    IncorporationPrivate company with limited liability